Autopsy report · NCT03705858

Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.

“Due to difficulty in finalizing the contract”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Joseph Jurcic
Sponsor type: University, hospital or other
Conditions: Acute Myeloid Leukemia
Interventions: Ac-Lintuzumab
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.